See also this year's filing and all EDGAR filings for this company.
PDF Report 0001279704_2023_Cellectar_Biosciences_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001279704, Cellectar Biosciences Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 20,529,601 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 418,641 |
3 | remainder_Assets | 641,548 |
4 | LiabilitiesCurrent | 5,529,290 |
5 | LiabilitiesNoncurrent | 552,981 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 9,594,170 |
9 | ResearchAndDevelopmentExpense | 19,219,603 |
10 | remainder_Expenses | -60,000 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 152,519 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 21,589,790 |
1 | Liabilities | 6,082,271 |
2 | Expenses | 28,753,773 |
3 | Revenues | 0 |
4 | StockholdersEquity | 15,507,519 |
5 | NetIncome | -28,601,254 |
6 | ComprehensiveNetIncome | -28,601,254 |
7 | BaseVar | 28,289,176 |
8 | EconomicCapitalRatio | -0.139 |